News & Updates
Showing Obstetrics & Gynaecology articles
Showing

TNF inhibition beyond 24 weeks: How safe in pregnant mums?
Continued treatment with tumor necrosis factor (TNF) inhibitors after 24 weeks of pregnancy appears safe and is associated with lower chances of maternal inflammatory bowel disease (IBD) relapse, without increasing adverse neonatal outcomes, new research suggests.

Gestational diabetes diagnosis: Does lower glycaemic threshold affect maternal, birth outcomes?
Using a lower glycaemic threshold led to more diagnoses of gestational diabetes, though its impact on maternal and birth outcomes remains uncertain, results of the GEMS* trial showed.

Extending letrozole treatment beyond 5 days induces ovulation in certain PCOS patients
For women with polycystic ovary syndrome (PCOS), if a 5-day letrozole regimen for ovulation induction does not work, extending the duration of treatment may do the job, as shown in a study.

Vitamin D, aspirin, exercise reduce pregnancy-related hypertension
There appears to be several ways to reduce the risk of pre-eclampsia and pregnancy-induced hypertension. These include low molecular weight heparin (LMWH), vitamin D supplementation, calcium supplementation, aspirin, and exercise, according to a meta-analysis.




